Data Integrity Guide: Spreadsheet Validation
Strengthen Spreadsheet Controls. Reduce Compliance Risk. Spreadsheets remain one of the most widely used tools across pharmaceutical operations, supporting everything from laboratory calculations and stability programs to equipment maintenance, quality systems, and product release decisions. […]
The Next Episode | What 13 Years of DSCSA Teach Us About NDC-12 and Pharmaceutical Interoperability
The Transactions Haven’t Changed. The Network Has. Flying home from the HDA Traceability Seminar last week, I saw some news from Philadelphia that put much of what we had spent the previous few days discussing […]
When Distribution Models Change Faster Than Controls: GLP-1, DTC, and the New Pharmaceutical Risk Landscape
Within this slide deck, you can explore how GLP-1 demand, telehealth, digital pharmacies, and direct-to-consumer distribution are reshaping the pharmaceutical supply chain and creating new patient safety and security challenges. Rx-360’s Ryan Kelly, Interim CEO […]
Supplier Assessment Questionnaire (SAQ) Guide
TURN INSIGHT INTO ACTION WITH THE RX‑360 SAQ GUIDE The Rx‑360 Supplier Assessment Questionnaire (SAQ) Guide provides a practical walkthrough of how to effectively use the SAQ within your supplier qualification program. Designed as a […]
What the 2026 EU GMP Annex 1 Update Means for Veterinary Product Supplier Qualification
he 2026 EU GMP Annex 1 Update Means for Veterinary Product Supplier Qualification The 2026 EU GMP Annex 1 changes mark a major regulatory shift, introducing a full separation between human and veterinary manufacturing requirements. […]
Supplier Corrective Action Report Web Form
Optimize Supplier Corrective Actions with Rx‑360’s SCAR Template The Supplier Quality Working Group at Rx‑360 has developed a standardized Supplier Corrective Action Report (SCAR) template designed to strengthen pharmaceutical supply chain integrity and improve quality […]
Rx-360 Reaffirms Compliance with NMPA Requirements | Download the Position Letter
Rx-360 is committed to supporting the global pharmaceutical industry in meeting regulatory standards worldwide. In response to the National Medical Products Administration (NMPA) release of Appendices One and Two of Article 310 of the Good […]
The BIOSECURE Act and the Quiet Work Ahead for Pharmaceutical Supply Chains
The BIOSECURE Act did not arrive with ceremony. It arrived embedded in the National Defense Authorization Act, debated largely in abstractions, and passed with little public attention. But for pharmaceutical and biotechnology companies operating global […]
Prevention of Reuse of Genuine Packaging Components for Counterfeit Products
“Prevention of Reuse of Genuine Packaging Components for Counterfeit Products” addresses the growing threat of counterfeit pharmaceutical products entering the legitimate supply chain through the reuse of genuine packaging components. Counterfeiters often retrieve discarded packaging—such […]